TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06054243

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT-I
Description: The intervention will consist of eight weekly group sessions (120-min, 5-8 adolescents in each group) delivered within a 10-week windows. The treatment components aim to address the behavioural, cognitive and physiological factors perpetuating insomnia whilst considering the sleep and circadian features in adolescents and developmental context with the following key elements: psychoeducation about sleep, circadian rhythm and sleep hygiene, stimulus control, sleep restriction, relaxation training, structured worry time, cognitive restructuring (targeting sleep-related dysfunctional cognitions), and relapse prevention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT-A
Description: The intervention will consist of eight weekly group sessions (120-min, 5-8 adolescents in each group) delivered within a 10-week windows. The CBT-A treatment is modified from the Coping Cat programme, which incorporates psychoeducation and the core behavioural strategies and cognitive skills for managing anxiety (e.g. exposure, relaxation training, cognitive restructuring).
Study: NCT06461221

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound in one of the 4 stimulation conditions

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound in one of the 4 stimulation conditions

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound in one of the 4 stimulation conditions

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Focused Ultrasound
Description: Using MRI-guided targeting, we will administer focused ultrasound in one of the 4 stimulation conditions
Study: NCT05176548

Intervention type: DIAGNOSTIC_TEST
Intervention: Bone-cardiac scintigraphy
Description: Patients with confirmed ATTR type CA will undergo a study of mutations in the TTR gene

Intervention type: DIAGNOSTIC_TEST
Intervention: Bone-cardiac scintigraphy
Description: Patients with confirmed ATTR type CA will undergo a study of mutations in the TTR gene
Study: NCT06349122

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: Metronidazole ovules: In case of Trichomonas vaginalis infection during the 1st trimester of pregnancy: 1 ovule morning and evening for 14 days (French Society of Dermatology Recommendations 2016); Metronidazole 500 mg tablets in case of Trichomonas vaginalis infection during the 2nd or the 3rd trimester of pregnancy in a single dose of 2 g

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clotrimazole, Vaginal
Description: In case of Candida albicans infection in a single dose to be repeated up to 6 times if necessary.
Study: NCT05670314

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin Fibre supplement
Description: 20g/ day. Inulin is easily dissolvable in liquid and can be incorporated into the usual diet - by adding to water, juice, smoothies, cereal, yogurt etc.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin Fibre supplement
Description: 20g/ day. Inulin is easily dissolvable in liquid and can be incorporated into the usual diet - by adding to water, juice, smoothies, cereal, yogurt etc.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin (Placebo)
Description: 10g/ day which can be consumed by adding to breakfast cereal/ smoothie/ yogurt or drink of choice

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Joint Academy An app-based exercises platform (Joint Academy®) will be used as an intervention given to the treatment arm. The programme consists of a mixture of open and close chain exercises, a combination of concentric, eccentric and focusing on the global strength of legs including the muscles around the hips and knee joints as well as balance enhancement exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Joint Academy An app-based exercises platform (Joint Academy®) will be used as an intervention given to the treatment arm. The programme consists of a mixture of open and close chain exercises, a combination of concentric, eccentric and focusing on the global strength of legs including the muscles around the hips and knee joints as well as balance enhancement exercises.
Study: NCT05288296

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dynamic taping
Description: 1. The intervention of dynamic tape can improve the LESS, which also means that we may reduce the probability of ACL injury through the intervention of dynamic tape.~2. By establish a native model of single-leg and double-leg LESS can predict the occurrence of ACL injury early and further prevent it.
Study: NCT03081806

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: X0002
Description: Subjects will complete 22 weeks of double-blind treatment and then enter into 30 weeks open-label treatment.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: X0002
Description: Subjects will complete 22 weeks of double-blind treatment and then enter into 30 weeks open-label treatment.
Study: NCT06010420

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: insoles
Description: Insoles are support devices that take the shape of the foot structure and enable the foot to press in a correct form.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: insoles
Description: Insoles are support devices that take the shape of the foot structure and enable the foot to press in a correct form.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: insoles
Description: Insoles are support devices that take the shape of the foot structure and enable the foot to press in a correct form.
Study: NCT05356975

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Superset
Description: A strength circuit training will be performed in a supersets fashion. Three strength circuit training in three blocks.~1. One leg squat, side plank, and push up.~2. Deadlift, lumbar extension stretch, and row.~3. Glute bridge, crunches, and front raise.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent
Description: Six resistance exercises in a traditional fashion: three exercises for the lower body (one leg squat, deadlift, and glute bridge). Three exercises for the upper body (push up, row, and front raise). And three aerobic exercises (floor tap squat, jumping jacks, and skaters).
Study: NCT06526078

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Sessions of cognitive training exercises (15-20min each) self-administered via a web app

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Training
Description: Sessions of sham training exercises (15-20min each) self-administered via a web app
Study: NCT04888845

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Safety Plan
Description: The safety plan is a written, prioritized list of coping strategies and resources for reducing suicide risk.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Safety Plan
Description: The safety plan is a written, prioritized list of coping strategies and resources for reducing suicide risk.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Crisis Response Plan
Description: Crisis response planning intervention teaches a range of coping strategies and provides support that can reduce suicide attempts and ideation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Crisis Response Plan
Description: Crisis response planning intervention teaches a range of coping strategies and provides support that can reduce suicide attempts and ideation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured interview
Description: In the structured interview approach, clinicians ask a series of predetermined questions and/or assess a specified set of risk and protective factors, typically using a checklist-based approach.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured interview
Description: In the structured interview approach, clinicians ask a series of predetermined questions and/or assess a specified set of risk and protective factors, typically using a checklist-based approach.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Narrative Assessment
Description: In the narrative assessment approach, clinicians ask patients to tell the story of their suicidal crisis.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Narrative Assessment
Description: In the narrative assessment approach, clinicians ask patients to tell the story of their suicidal crisis.
Study: NCT05882695

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPG302
Description: synthetic small molecule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPG302
Description: synthetic small molecule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPG302
Description: synthetic small molecule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPG302
Description: synthetic small molecule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06237413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZG2001 Tosilate Tablets
Description: ZG2001 will be administered orally once or twice daily in a continuous regimen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZG2001 Tosilate Tablets
Description: ZG2001 will be administered orally once or twice daily in a continuous regimen
Study: NCT05883059

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lower limb robot assisted walking training
Description: The participants in the robot group received lower limb robot assisted walking training combined with routine rehabilitation therapy. Lower limb robot assisted walking training for 30 minutes each time, once a day, 5 times a week, for 4 consecutive weeks; Routine rehabilitation treatment includes lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, functional electrical stimulation, etc. Routine rehabilitation treatment once a day, five times a week, for four consecutive weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: routine rehabilitation
Description: The control group participants received routine rehabilitation, including lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, functional electrical stimulation, etc. Routine rehabil
Study: NCT06454422

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: wu qinxi
Description: Wuqinxi, also known as the Hundred-step Sweating Exercise, is one of the most emblematic Health qigong exercises. Huatuo, guided by the principle, formulated the 'Wuqinxi':  Running water is never stale and a door-hinge is never gets worm-eaten, and sums up the experiences of the fitness activities of Huatuo's predecessors that imitate the movements of tigers, deer, bears, apes, birds, and other animals, and are associated with human organs, meridians, and 'qi'
Study: NCT06255379

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fuquinitinib+Tegafur Gimeracil Oteracil
Description: Fuquinitinib:5 mg once daily, 2 weeks on/1 week off,q3w; Tegafur Gimeracil Oteracil:BSA(body surface area)\< 1.2m2,40mg/m2,p.o,bid,2 weeks on/1 week off,q3w; 1.2m2 \< BSA （body surface area）\< 1.5m2,50mg/m2,p.o,bid,2 weeks on/1 week off,q3w;BSA（body surface area） \>1.5m2,60mg/m2,p.o,bid,2 weeks on/1 week off,q3w;
Study: NCT05520021

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nifedipine
Description: A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulfate
Description: A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Study: NCT05821790

Intervention type: OTHER
Intervention: Surgical waste and Data collect
Description: Samples required for the study will be obtained from surgical waste of patients who underwent meningioma resection. Data necessary for the study will be collected from the patient's medical records, MRI examinations, and data specific to the characteristics of the surgical waste.
Study: NCT05977075

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ApisMela protocol
Description: The activities and games proposed by this protocol are offered in a sequence characterized by increasing complexity. The same function is stimulated with varied tasks because the repetitiveness of the same task negatively affects skill generalization. ApisMela training teaches to focus on the purpose of the task, check that you understand it, and make explicit the procedures to be implemented. Language plays a crucial role, participants are encouraged to use speech as a tool for attention regulation and cognitive processing. It's divided into 20 sessions: a weekly group meeting of one hour and thirty.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ApisMela protocol
Description: The activities and games proposed by this protocol are offered in a sequence characterized by increasing complexity. The same function is stimulated with varied tasks because the repetitiveness of the same task negatively affects skill generalization. ApisMela training teaches to focus on the purpose of the task, check that you understand it, and make explicit the procedures to be implemented. Language plays a crucial role, participants are encouraged to use speech as a tool for attention regulation and cognitive processing. It's divided into 20 sessions: a weekly group meeting of one hour and thirty.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unstuck and on Target protocol
Description: The protocol teaches people to be more flexible, skillful in planning and goal-oriented. It is useful for moving more easily from one topic to another and from one task to another, considering new ideas or another person's point of view, generalizing skills learned across contexts so that teachers, parents and therapists can focus more on educational aspects and less on behavioral management. It is divided into 20 sessions: a weekly group meeting of one hour and thirty minutes. A homework sheet is provided for each session to consolidate the skill learned and generalize it outside the work setting. Parents have an active role in performing the task.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unstuck and on Target protocol
Description: The protocol teaches people to be more flexible, skillful in planning and goal-oriented. It is useful for moving more easily from one topic to another and from one task to another, considering new ideas or another person's point of view, generalizing skills learned across contexts so that teachers, parents and therapists can focus more on educational aspects and less on behavioral management. It is divided into 20 sessions: a weekly group meeting of one hour and thirty minutes. A homework sheet is provided for each session to consolidate the skill learned and generalize it outside the work setting. Parents have an active role in performing the task.
Study: NCT05896683

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazertinib
Description: Lazertinib will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazertinib
Description: Lazertinib will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazertinib
Description: Lazertinib will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazertinib
Description: Lazertinib will be administered orally.
Study: NCT06288269

Intervention type: OTHER
Intervention: Severity of Stroke and 1 year survival
Description: Evaluated from NIHSS and clinical outcome 1 year survival death

Intervention type: OTHER
Intervention: Severity of Stroke and 1 year survival
Description: Evaluated from NIHSS and clinical outcome 1 year survival death
Study: NCT05631106

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Resistance Training
Description: During each group exercise session, the participants will be guided through a 5-minute warm-up, supervised to perform two sets of machine-based leg press, chest press, seated row, and shoulder press exercises at 30% of 1-RM, and guided through a cool-down. Each exercise set will be 40 -seconds in length with instructions to perform as many repetitions as possible followed by a 20-second rest in between sets and a three-minute rest between exercises.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stretching, Balance, and Range of motion
Description: The stretching, balance, and range of motion intervention will include a rotating and varied routine of stretching exercises for large and small muscle groups, and activities to improve balance and range of motion. Participants will attend this intervention twice a week with each session lasting 30 minutes.
Study: NCT06230666

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: SBRT
Description: Stereotactic Body Radiation Therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: Stereotactic Body Radiation Therapy
Study: NCT06349122

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Patients will not be screened using molecular biology techniques in this group. The management of these patients is a matter of routine for health professionals. They will be free to prescribe a standard vaginal swab if symptoms are present and to treat their patients according to their usual protocols. No routine sampling is recommended in the absence of a history
Study: NCT04676711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GFH312
Description: Subjects are planned to be dosed in oral tablet, with single and multiple ascending doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects are planned to be dosed in oral tablet, with single and multiple ascending doses
Study: NCT04709705

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Human platelets
Description: Platelets given to control bleeding

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Human platelets
Description: Platelets given to control bleeding
Study: NCT05192408

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Description: Individual intervention will comprise:~1. Cognitive- behavioral therapy (CBT) which includes: - Behavioural activation, cognitive restructuring, promotion of safety, relaxation techniques~2. Exercise recommendation utilizing current Exercise in older adults Patient Education Materials (PEMs) and videos, tailored based on frailty level and readiness to progress - Components include balance and strength~3. Use of motivational interviewing (MI) techniques for goal setting~There will be 4 sessions in total. Initial sessions will be carried out face to face or via videoconferencing platform if participant prefers due to ongoing COVID-19 pandemic. Subsequent sessions will be carried out via telephone.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Patient Education Materials
Study: NCT04576065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WFIT
Description: access to nurse practitioner for telehealth visits and activity monitor for 6 months after hospital discharge
Study: NCT04888715

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWN12088
Description: Prolyl-tRNA synthetase (PRS) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWN12088
Description: Prolyl-tRNA synthetase (PRS) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: Pirfenidone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nintedanib
Description: Nintedanib
Study: NCT06266156

Intervention type: BEHAVIORAL
Intervention: Score of anxiety questionnaire
Description: All participants were answered the dental anxiety questionnaire.

Intervention type: BEHAVIORAL
Intervention: Score of anxiety questionnaire
Description: All participants were answered the dental anxiety questionnaire.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate
Description: All participants heart rate were measured with finger type pulse oxymeter.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate
Description: All participants heart rate were measured with finger type pulse oxymeter.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oxygen saturation
Description: All participants oxygen saturation were measured with finger type pulse oxymeter.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oxygen saturation
Description: All participants oxygen saturation were measured with finger type pulse oxymeter.
Study: NCT05137340

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure and Non-invasive positive pressure ventilation
Description: After transfer to NICU ward, infants were randomly assigned to NCPAP group and NIPPV group. Patients diagnosed with NRDS on non-invasive respiratory support (NIPPV or NCPAP) were given a therapeutic dose of pulmonary surfactant via MISA within 120 minutes after birth.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nasal continuous positive airway pressure and Non-invasive positive pressure ventilation
Description: After transfer to NICU ward, infants were randomly assigned to NCPAP group and NIPPV group. Patients diagnosed with NRDS on non-invasive respiratory support (NIPPV or NCPAP) were given a therapeutic dose of pulmonary surfactant via MISA within 120 minutes after birth.